A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection
- Sponsor:
- Curium
- Sponsor Study ID:
- CURCu64PSM0003
- CTO #:
- 104002
- NCT Number:
- NCT06235151
- Phase:
- III
- Protocol Type:
- Diagnostic
- Age Group:
- Adults
- Disease Sites:
- Prostate
- Study Objectives:
- To determine the patient-level Correct Detection Rate (CDR) of copper Cu 64 PSMA I&T PET/CT in patients with Biochemical Recurrence (BCR) of PC. To determine the region-level Correct Localization Rate (CLR) of Copper Cu 64 PSMA I&T PET/CT in patients with BCR of PC.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Grubb, Robert, at grubbr@musc.edu .
- Study Coordinator, Tucker, Renee, at tuckerr@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina